Felix Baker serves as Executive at VIROPHARMA INC, where they oversee executive responsibilities. Since joining the company, Felix Baker has executed 1261 insider transactions totaling $2.3B, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 17, 2022 involved purchasing 7,300 shares valued at $492.0K.
Felix Baker currently holds 7,955,916 shares of VIROPHARMA INC (VPHM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Felix Baker has been a net buyer of VPHM stock. They have purchased $1.6B and sold $679.1M worth of shares.
Felix Baker's most recent insider trade was on Feb 17, 2022, when they purchased 7,300 shares at $67.40 per share.
Get notified when new Form 4 filings are submitted
| $67.74 |
| Discretionary |
| Jan 25, 2022 | KOD | $323.9K | Purchase | 5,500 | $58.90 | Discretionary |
| Jan 24, 2022 | KOD | $549.4K | Purchase | 9,350 | $58.76 | Discretionary |
| Jan 24, 2022 | KOD | $7.7M | Purchase | 132,367 | $58.13 | Discretionary |
| Jan 24, 2022 | KOD | $1.5M | Purchase | 25,900 | $57.59 | Discretionary |
| Jan 24, 2022 | KOD | $6.6M | Purchase | 116,083 | $56.87 | Discretionary |
| Jan 24, 2022 | KOD | $67.9K | Purchase | 1,200 | $56.60 | Discretionary |
| Jan 24, 2022 | KOD | $1.1M | Purchase | 19,750 | $56.39 | Discretionary |
| Jan 24, 2022 | KOD | $3.4M | Purchase | 57,547 | $58.87 | Discretionary |
| Jan 21, 2022 | KOD | $1.8M | Purchase | 31,207 | $57.53 | Discretionary |
| Jan 21, 2022 | KOD | $5.8M | Purchase | 102,207 | $56.57 | Discretionary |
| Jun 30, 2021 | INCY | $0 | Award | 345 | $N/A | Discretionary |
| Jun 30, 2021 | INCY | $0 | Award | 345 | $N/A | Discretionary |
| Jun 22, 2021 | ACAD | $0 | Award | 12,782 | $N/A | Discretionary |
| Jun 22, 2021 | ACAD | $0 | Award | 12,782 | $N/A | Discretionary |
| May 14, 2021 | INCY | $379.4K | Option Exercise | 20,000 | $18.97 | Discretionary |
| May 14, 2021 | INCY | $379.4K | Option Exercise | 20,000 | $18.97 | Discretionary |
| Jan 27, 2021 | IGMS | $234.9K | Option Exercise | 5,833 | $40.27 | Discretionary |
| Jan 27, 2021 | IGMS | $234.9K | Option Exercise | 5,833 | $40.27 | Discretionary |
| Jan 27, 2021 | IGMS | $86.0K | Option Exercise | 5,377 | $16.00 | Discretionary |
| Jan 27, 2021 | IGMS | $86.0K | Option Exercise | 5,377 | $16.00 | Discretionary |
| Jan 4, 2021 | BGNE | $2.2M | Sale | 10,060 | $220.50 | Discretionary |
| Jan 4, 2021 | BGNE | $24.5M | Sale | 111,094 | $220.50 | Discretionary |
| Dec 31, 2020 | INCY | $0 | Award | 343 | $N/A | Discretionary |
| Dec 31, 2020 | INCY | $0 | Award | 343 | $N/A | Discretionary |
| Dec 4, 2020 | BGNE | $27.7M | Sale | 125,513 | $220.50 | Discretionary |
| Dec 4, 2020 | BGNE | $305.6M | Sale | 1,386,033 | $220.50 | Discretionary |
| Oct 13, 2020 | BGNE | $0 | Gift | 13,516 | $N/A | Discretionary |
| Oct 13, 2020 | BGNE | $0 | Gift | 13,516 | $N/A | Discretionary |